Meaningful insights into your baby’s health

Sema4 Noninvasive Prenatal Select is a simple blood test that can detect chromosomal abnormalities as early as 9 weeks into pregnancy



Actionable insights into solid tumor cancers

Sema4 Solid Tumor Panel analyzes 161 of the most relevant cancer driver genes to help doctors find the right treatment, the first time



Test Catalog

Our comprehensive offering of genetic tests

With state-of-the-art technology, high detection rates, and an unparalleled service model, our lab provides simple and accurate genetic and genomic screening. Our testing catalog includes molecular, cytogenetic, and biochemical analyses, allowing for the accommodation of even the most unique of cases.


More Than Just a Test.

Sema4 merges data and science to help our partners identify, target and validate novel predictive and prognostic biomarkers.

Through our unique data, tools, interrogation, predictive models, and expertise we are improving outcomes for our partners, such as Janssen.